Livforsakringsbolaget Skandia Omsesidigt Sells 600 Shares of Colgate-Palmolive (NYSE:CL)

Livforsakringsbolaget Skandia Omsesidigt cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 30.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,346 shares of the company’s stock after selling 600 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Colgate-Palmolive were worth $131,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Federated Hermes Inc. grew its holdings in Colgate-Palmolive by 560.2% during the 4th quarter. Federated Hermes Inc. now owns 288,537 shares of the company’s stock valued at $22,999,000 after buying an additional 244,834 shares in the last quarter. Mitchell Sinkler & Starr PA increased its holdings in Colgate-Palmolive by 92.6% in the 4th quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock valued at $3,659,000 after acquiring an additional 22,073 shares during the last quarter. Xponance Inc. lifted its stake in Colgate-Palmolive by 7.9% in the 4th quarter. Xponance Inc. now owns 182,775 shares of the company’s stock worth $14,569,000 after purchasing an additional 13,342 shares in the last quarter. Stonehage Fleming Financial Services Holdings Ltd boosted its holdings in shares of Colgate-Palmolive by 57.1% during the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares during the last quarter. Finally, D L Carlson Investment Group Inc. purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $3,269,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Sally Massey sold 15,850 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Trading Down 1.1 %

Colgate-Palmolive stock traded down $1.16 during trading hours on Monday, hitting $100.91. The company had a trading volume of 1,272,638 shares, compared to its average volume of 4,413,266. The firm has a market cap of $82.79 billion, a P/E ratio of 32.30, a P/E/G ratio of 3.54 and a beta of 0.39. The company has a 50-day moving average price of $97.49 and a two-hundred day moving average price of $91.66. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $104.15. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same period last year, the business posted $0.77 EPS. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.98%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Barclays boosted their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. BNP Paribas initiated coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price for the company. Bank of America raised their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.